Rezolute (RZLT) Prepaid Assets (2011 - 2026)
Rezolute (RZLT) posted Prepaid Assets of $1.8 million for Q1 2026, down 17.85% sequentially from $2.2 million in Q4 2025, and down 3.36% YoY from $1.8 million in Q1 2025.
Analysis
Rezolute (RZLT) Prepaid Assets (2011 - 2026) Analysis & Trends
Rezolute has reported Prepaid Assets for 16 years, with the latest figure at $1.8 million in Q1 2026.
- Quarterly Prepaid Assets fell 3.36% year-over-year to $1.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 million (down 3.36% YoY) and the FY2025 annual result came in at $3.3 million, up 84.77% from the prior year.
- Prepaid Assets eased to $1.8 million in Q1 2026 per RZLT's latest filing, from $2.2 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $3.9 million in Q3 2023 and troughed at $860000.0 in Q4 2022.
- A 5-year average of $2.2 million and a median of $2.2 million in 2024 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2022 and 2024: Prepaid Assets surged 344.17% in 2022, then sank 51.34% in 2024.
- Over 5 years, Prepaid Assets stood at $860000.0 in 2022, then soared by 305.47% to $3.5 million in 2023, then tumbled by 38.23% to $2.2 million in 2024, then climbed by 0.65% to $2.2 million in 2025, then slipped by 17.85% to $1.8 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $1.8 million, $2.2 million, and $2.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn |
| 10 | Rezolute | 477.02 Mn | 477.02 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1.78 Mn |
| Dec 31, 2025 | 2.17 Mn |
| Sep 30, 2025 | 2.51 Mn |
| Jun 30, 2025 | 3.29 Mn |
| Mar 31, 2025 | 1.84 Mn |
| Dec 31, 2024 | 2.15 Mn |
| Sep 30, 2024 | 1.91 Mn |
| Jun 30, 2024 | 1.78 Mn |
| Mar 31, 2024 | 2.19 Mn |
| Dec 31, 2023 | 3.49 Mn |
| Sep 30, 2023 | 3.92 Mn |
| Jun 30, 2023 | 3.01 Mn |
| Mar 31, 2023 | 2.46 Mn |
| Dec 31, 2022 | 860,000.00 |
| Sep 30, 2022 | 1.31 Mn |
| Jun 30, 2022 | 1.69 Mn |
| Mar 31, 2022 | 915,000.00 |
| Dec 31, 2021 | 695,000.00 |
| Sep 30, 2021 | 1.05 Mn |
| Jun 30, 2021 | 946,000.00 |